Expert Ratings For OrthoPediatrics
7 analysts have expressed a variety of opinions on OrthoPediatrics (NASDAQ:KIDS) over the past quarter, offering a diverse…
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation From FDA For eLLi Growing Rod System For Pediatric Patients With Scoliosis
OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it has received the "Breakthrough Device" Designation from the Food
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Analysts’ ratings for OrthoPediatrics (NASDAQ:KIDS) over the last quarter vary from bullish to bearish, as provided by 6…
Decoding 5 Analyst Evaluations For OrthoPediatrics
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on OrthoPediatrics (NASDAQ:KIDS)…
OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights For Q4 & FY23; Sees Q4 Revenue $37.6M Vs $37.77M Est.; FY23 Revenue $148.7M Vs $148.88M Est.; Sees FY24 Revenue $197M-$200M Vs $177.7M Est
OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited net revenue for the fourth
OrthoPediatrics Corp. Announces Acquisition Of Boston Orthotics & Prosthetics For An Upfront Cash Payment Of $22M; Closes $80M Debt Financing To Support Acquisition And Future Business Requirements
Combined organizations have helped more than 1 million kids Expands Specialty Bracing Division with pediatric orthotic management business offering leading technology and pediatric care through dedicated
Analyst Ratings for OrthoPediatrics
OrthoPediatrics (NASDAQ:KIDS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell
• Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
